Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCMSCs for Newly Diagnosed Type 1 Diabetes
NCT06407297Phase 2Recruiting
- Sponsor
- Shanghai Changzheng Hospital
- Start
- May 2024
- Primary completion
- Sep 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in type 1 diabetes mellitus (T1D), sponsored by Shanghai Changzheng Hospital. Started May 2024; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT06407297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06407297.